[1]
M. S and K. KUMAR M, “PERSPECTIVES OF CLINICAL EXPERTS ON THE CURRENT USAGE PATTERNS AND THE PREFERENCE OF VILDAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES”, Innovare J Med Sci, vol. 12, no. 2, pp. 1–3, Mar. 2024.